Home › Chronic Kidney Disease › Tennessee › Memphis
Chronic Kidney Disease clinical trials in Memphis, TN
5 studies for Chronic Kidney Disease are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Olive Branch Family Medical Center, Olive Branch · 18 mi away
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
- University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Recruiting
- Memphis VA Medical Center, Memphis, TN, Memphis
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Recruiting
- James Eric Gardner, MD, PC, Memphis
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Recruiting
- University of Tennessee Health Science Center/Regional One Health, Memphis
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY16 studies
- Boston, MA15 studies
- Houston, TX15 studies
- Dallas, TX15 studies
- Philadelphia, PA15 studies
- Chicago, IL13 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Durham, NC9 studies
- Kansas City, MO9 studies
- Albuquerque, NM8 studies
- San Antonio, TX8 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Sickle Cell Disease18 studies
- Lung Cancer18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.